1 Min Read
Roche Holding AG:
* SAYS POSITIVE PHASE III RESULTS FOR ROCHE’S HEMLIBRA FOR HAEMOPHILIA A WITHOUT FACTOR VIII INHIBITORS PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.